Literature DB >> 16271474

Synthesis and interactions of 7-deoxy-, 10-deacetoxy, and 10-deacetoxy-7-deoxypaclitaxel with NCI/ADR-RES cancer cells and bovine brain microvessel endothelial cells.

Haibo Ge1, Veena Vasandani, Jacquelyn K Huff, Kenneth L Audus, Richard H Himes, Anna Seelig, Gunda I Georg.   

Abstract

7-Deoxypaclitaxel, 10-deacetoxypaclitaxel and 10-deacetoxy-7-deoxypaclitaxel were prepared and evaluated for their ability to promote assembly of tubulin into microtubules, their cytotoxicity against NCI/ADR-RES cells and for their interactions with P-glycoprotein in bovine brain microvessel endothelial cells. The three compounds were essentially equivalent to paclitaxel in cytotoxicity against NCI/ADR-RES cells. They also appeared to interact with P-glycoprotein in the endothelial cells with the two 10-deacetoxy compounds having less interaction than paclitaxel and 7-deoxypaclitaxel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271474     DOI: 10.1016/j.bmcl.2005.09.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis of docetaxel and butitaxel analogues through kinetic resolution of racemic beta-lactams with 7-O-triethylsilylbaccatin III.

Authors:  Haibo Ge; Jared T Spletstoser; Yan Yang; Margaret Kayser; Gunda I Georg
Journal:  J Org Chem       Date:  2007-02-02       Impact factor: 4.354

2.  Paclitaxel succinate analogs: Anionic and amide introduction as a strategy to impart blood-brain barrier permeability.

Authors:  Brandon J Turunen; Haibo Ge; Jariat Oyetunji; Kelly E Desino; Veena Vasandani; Sarah Güthe; Richard H Himes; Kenneth L Audus; Anna Seelig; Gunda I Georg
Journal:  Bioorg Med Chem Lett       Date:  2008-10-02       Impact factor: 2.823

3.  Synthesis, tubulin assembly, and antiproliferative activity against MCF7 and NCI/ADR-RES cancer cells of 10-O-acetyl-5'-hydroxybutitaxel.

Authors:  Haibo Ge; Jianmei Wang; Margaret M Kayser; Richard H Himes; Gunda I Georg
Journal:  Bioorg Med Chem Lett       Date:  2008-10-07       Impact factor: 2.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.